Elsevier R&D Solutions for Pharma and Life Science: extracts from Elsevier’s whitepaper
THE FUNDAMENTALS OF MONITORING LITERATURE
Monitoring literature for product citations would be an impossible task if not for modern research informatics solutions. Corporate, academic and government pharmaceutical and medical research facilities produce in excess of 20 terabytes of data per day.
Even with only a fraction of this data making it into peer-reviewed journals and conference proceedings, without the support of dedicated informatics solutions, pharmacovigilance teams and researchers would need to spend incredible amounts of time sifting through heterogeneous data and cross-disciplinary reports before they could gain the required information. There would also be a real risk of missing important data due to the sheer volume of information to be reviewed…
HOW CAN LITERATURE SCREENING AND TRIAGE BE MOST EFFECTIVE
To function effectively, all types of biomedical literature must be covered. Pharmaceutical companies and medical device manufacturers cannot afford to miss any product mentions, so their literature screening solution must give access to more than just peer-reviewed journals. Conference abstracts and proceedings, preclinical and clinical trial documents, and patient and healthcare provider reports are all key documents in pharmacovigilance and medical device surveillance…
EMBASE AND QUOSA – THE IDEAL PARTNERSHIP
Embase and QUOSA combine to form an ideal solution for pharmacovigilance, post-market medical device surveillance and product strategy planning. They cover all the required bases – from comprehensive literature access to user-friendly data management. Together, they allow research and information professionals to manage full-text information efficiently, with an unmatched functionality for literature screening, organization, archiving and sharing.